Cargando…

Adenosine A(2A) receptors modulate BDNF both in normal conditions and in experimental models of Huntington’s disease

Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, enhances synaptic transmission and regulates neuronal proliferation and survival. Functional interactions between adenosine A(2A) receptors (A(2A)Rs) and BDNF have been recently reported. In this article, we report some r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Potenza, R. L., Tebano, M. T., Martire, A., Domenici, M. R., Pepponi, R., Armida, M., Pèzzola, A., Minghetti, L., Popoli, P.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2007
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2072926/ https://www.ncbi.nlm.nih.gov/pubmed/18404446 http://dx.doi.org/10.1007/s11302-007-9066-y

Ejemplares similares

Is the functional interaction between adenosine A(2A) receptors and metabotropic glutamate 5 receptors a general mechanism in the brain? Differences and similarities between the striatum and the hippocampus
por: Tebano, M. T., et al.
Publicado: (2006)

Role of Adenosine A(2A) Receptors in Modulating Synaptic Functions and Brain Levels of BDNF: a Possible Key Mechanism in the Pathophysiology of Huntington's Disease
por: Tebano, Maria Teresa, et al.
Publicado: (2010)

Adenosine A(2A) receptor stimulation restores cell functions and differentiation in Niemann-Pick type C-like oligodendrocytes
por: De Nuccio, Chiara, et al.
Publicado: (2019)

P2X7 Receptor Agonist 2′(3′)-O-(4-Benzoylbenzoyl)ATP Differently Modulates Cell Viability and Corticostriatal Synaptic Transmission in Experimental Models of Huntington’s Disease
por: Martire, Alberto, et al.
Publicado: (2021)

Adenosine A(2A) receptor inhibition reduces synaptic and cognitive hippocampal alterations in Fmr1 KO mice
por: Ferrante, Antonella, et al.
Publicado: (2021)

Functional Interaction between Adenosine A(2A) and mGlu(5) Receptors Mediates STEP Phosphatase Activation and Promotes STEP/mGlu(5)R Binding in Mouse Hippocampus and Neuroblastoma Cell Line
por: Mallozzi, Cinzia, et al.
Publicado: (2023)

A Role for Oxidized DNA Precursors in Huntington's Disease–Like Striatal Neurodegeneration
por: De Luca, Gabriele, et al.
Publicado: (2008)

Insight into the Role of the STriatal-Enriched Protein Tyrosine Phosphatase (STEP) in A(2A) Receptor-Mediated Effects in the Central Nervous System
por: Domenici, Maria Rosaria, et al.
Publicado: (2021)

Myelin Defects in Niemann–Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives
por: Bernardo, Antonietta, et al.
Publicado: (2021)

Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction
por: Giralt, Albert, et al.
Publicado: (2011)

The Utility of BDNF Detection in Assessing Severity of Huntington’s Disease
por: Plinta, Klaudia, et al.
Publicado: (2021)

Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease
por: Pineda, Jose R, et al.
Publicado: (2009)

No association between polymorphisms in the BDNF gene and age at onset in Huntington disease
por: Mai, Maren, et al.
Publicado: (2006)

Localization of BDNF mRNA with the Huntington's disease protein in rat brain
por: Ma, Bin, et al.
Publicado: (2010)

Functional analysis of brain derived neurotrophic factor (BDNF) in Huntington’s disease
por: Zhou, Zhike, et al.
Publicado: (2021)

IKK cuts both ways in Huntington's disease
por: Short, Ben
Publicado: (2009)

Expression and Dendritic Trafficking of BDNF-6 Splice Variant are Impaired in Knock-In Mice Carrying Human BDNF Val66Met Polymorphism
por: Mallei, Alessandra, et al.
Publicado: (2015)

Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells
por: Donnici, Lorena, et al.
Publicado: (2008)

Decreased BDNF Release in Cortical Neurons of a Knock-in Mouse Model of Huntington’s Disease
por: Yu, Chenglong, et al.
Publicado: (2018)

Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis
por: Apolloni, Savina, et al.
Publicado: (2014)

Modulation of Phospho-CREB by Systemically Administered Recombinant BDNF in the Hippocampus of the R6/2 Mouse Model of Huntington's Disease
por: Paldino, Emanuela, et al.
Publicado: (2019)

Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants
por: Musazzi, Laura, et al.
Publicado: (2009)

Insomnia Impairs Both the Pro-BDNF and the BDNF Levels Similarly to Older Adults with Cognitive Decline: An Exploratory Study
por: Sánchez-García, Sergio, et al.
Publicado: (2023)

Cortical Axonal Secretion of BDNF in the Striatum Is Disrupted in the Mutant-huntingtin Knock-in Mouse Model of Huntington's Disease
por: Park, Hyungju
Publicado: (2018)

Repurposing Dipyridamole in Niemann Pick Type C Disease: A Proof of Concept Study
por: Pepponi, Rita, et al.
Publicado: (2022)

Rescue of Retinal Function by BDNF in a Mouse Model of Glaucoma
por: Domenici, Luciano, et al.
Publicado: (2014)

Acute stress induces an aberrant increase of presynaptic release of glutamate and cellular activation in the hippocampus of BDNF(Val/Met) mice
por: Musazzi, Laura, et al.
Publicado: (2022)

Adenosine Receptor Heteromers and their Integrative Role in Striatal Function
por: Ferré, Sergi, et al.
Publicado: (2007)

Divergent Effects of the Nonselective Adenosine Receptor Antagonist Caffeine in Pre-Manifest and Motor-Manifest Huntington’s Disease
por: Achenbach, Jannis, et al.
Publicado: (2022)

Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington’s Disease: Exercise, Adenosine Receptors and Ampakines
por: Cepeda, Carlos, et al.
Publicado: (2010)

Variation within the Huntington's Disease Gene Influences Normal Brain Structure
por: Mühlau, Mark, et al.
Publicado: (2012)

Prelimbic BDNF and TrkB signaling regulates consolidation of both appetitive and aversive emotional learning
por: Choi, D C, et al.
Publicado: (2012)

Suicidal behaviour in huntington disease
por: Freitas, R. Mota, et al.
Publicado: (2021)

Intracerebral Transplantation of BDNF-overexpressing Human Neural Stem Cells (HB1.F3.BDNF) Promotes Migration, Differentiation and Functional Recovery in a Rodent Model of Huntington's Disease
por: Kim, Hyun Sook, et al.
Publicado: (2020)

Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease
por: Giampà, Carmela, et al.
Publicado: (2013)

ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation
por: Zimmermann, Tina, et al.
Publicado: (2016)

Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients
por: Gutierrez, Ashley, et al.
Publicado: (2020)

Failure to Thrive: Impaired BDNF Transport along the Cortical–Striatal Axis in Mouse Q140 Neurons of Huntington’s Disease
por: Maloney, Michael T., et al.
Publicado: (2023)

Relevance of polymorphisms in MC4R and BDNF in short normal stature
por: Herrfurth, Nikolas, et al.
Publicado: (2018)

Lumbar Puncture Alleviates Chorea in a Patient with Huntington’s Disease and Normal Pressure Hydrocephalus
por: Shirani, Peyman, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_1flt8chq15pf6ml23dstj8oi21